CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00087789
Recruitment Status : Completed
First Posted : July 16, 2004
Last Update Posted : October 31, 2016
Information provided by (Responsible Party):
Sangamo Therapeutics ( Ceregene )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2010
  Actual Study Completion Date : May 2010